Journal of Cardiovascular Electrophysiology

FEBRUARY 20, 2025

Methods In this study, blood samples were collected from 16 patients before and 24h after pulmonary vein isolation (PVI) via a novel investigational PFA-based technology.

Biomarkers 40

Biomarkers Pulmonary Technology Ablation 40

Circulation

NOVEMBER 11, 2024

Background:Acquired mitochondrial dysfunction is one of the characteristics of pulmonary arterial hypertension (PAH). Exploring potential biomarkers from mitochondrial perspective may be effective in the diagnosis and treatment of PAH. ARMCX3 has strong stability and high accuracy in predicting PAH patients.

Biomarkers 40

Biomarkers Pulmonary Hypertension Circulation 40

Frontiers in Cardiovascular Medicine

DECEMBER 23, 2024

BackgroundPercutaneous mechanical thrombectomy (PMT) is increasingly used in the treatment of intermediate and high-risk acute pulmonary embolism (PE), and the treatment of high-risk PE with the aid of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has also been reported. The mortality rate was 27.3% during the 90-day follow-up.

Embolism 52

Embolism Pulmonary Cardiac Arrest Biomarkers 52

Frontiers in Cardiovascular Medicine

JULY 24, 2024

BackgroundThe relationship between human immunodeficiency virus (HIV) infection and pulmonary arterial hypertension (PAH) has garnered significant scrutiny. Individuals with HIV infection have a higher risk of developing PAH. However, the specific mechanism of HIV-associated PAH remains unclear.

Pulmonary 52

Pulmonary Hypertension Biomarkers Download 52

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies."

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Kidney Disease Research 52

Circulation

JANUARY 12, 2024

The dysfunction of pulmonary artery endothelial cells plays a pivotal role in the initiation and progression of pulmonary hypertension (PH). Blood samples were collected for biomarker examination from healthy donors or patients with hypoxic PH.

Pulmonary 45

Pulmonary Hypertension Biomarkers Circulation 45

Frontiers in Cardiovascular Medicine

APRIL 5, 2024

Inhaled NO has the unique ability to exert its vasodilatory effects in the pulmonary vasculature without any hypotensive side-effects in the systemic circulation. We will move on to the popular use of inhaled NO and will talk about the evidence base of the use of this selective pulmonary vasodilator.

Pediatrics 93

Pediatrics Pulmonary Biomarkers Innovation 93

DAIC

JULY 10, 2024

a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced success from a collaborative Phase II trial of ProtheraCytes for the treatment of acute myocardial infarction (AMI) led by CellProthera , as well as plans to continue the relationship into Phase III.

Myocardial Infarction 105

Myocardial Infarction Heart Failure Heart Attack Heart attacks 105

Journal of the American Heart Association

NOVEMBER 28, 2023

Exosomes containing microRNAs (miRs) have emerged as a novel biomarker. Transpulmonary exosomal miRs offer valuable insights into pulmonary circulation microenvironments. Using an in vitro flow model simulating the shear stress experienced by pulmonary endothelial cells, we observed a significant upregulation of miR‐21.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Pulmonary Heart Disease 40

CardiacWire

JANUARY 24, 2024

CardioSignal has already developed digital biomarkers for AFib and heart failure, while more solutions could be on the way for aortic stenosis, coronary artery disease, and pulmonary artery hypertension.

AFIB 75

AFIB Coronary Artery Disease Biomarkers Heart Failure 75

European Journal of Heart Failure

JANUARY 10, 2025

Abstract Aims A cardiovascular magnetic resonance (CMR) approach to non-invasively estimate left ventricular (LV) filling pressure was recently developed and shown to correlate with invasively measured pulmonary capillary wedge pressure (PCWP).

Heart Failure 40

Heart Failure Pulmonary Ultrasound Diabetes 40

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies."

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Research Academic 52

Circulation: Heart Failure

MARCH 5, 2025

EIH was defined as systolic blood pressure (BP) at peak exercise >210 mm Hg in men or >190 mm Hg in women.RESULTS:In this prospective cohort study, we assessed patients with COA (n=41, age 4314 years, 26 [63%] men) and healthy controls (n=41).

Exercise 40

Exercise Hypertension Outcomes Biomarkers 40

Circulation

NOVEMBER 11, 2024

Background:Pulmonary arterial hypertension (PAH) is characterized by an elevation in pulmonary vascular resistance and arterial pressure, culminating in right ventricular failure and mortality. Circulation, Volume 150, Issue Suppl_1 , Page A4142484-A4142484, November 12, 2024.

Pulmonary 40

Pulmonary Hypertension Biomarkers Circulation 40

Open Heart

JUNE 22, 2022

The objective of this study was to investigate the ability of insulin-like growth-factor binding protein 7 (IGFBP7), to predict c-AKI, AKI and RVF in patients undergoing cardiac surgery, as compared to N-terminal prohormone B-type natriuretic peptide (NT-pro-BNP) and pulmonary artery pulsatility index (PAPi).

Biomarkers 52

Biomarkers Pulmonary Outcomes 52

Heart BMJ

DECEMBER 20, 2023

Tricuspid valve replacement was performed in 26 (53%) patients including 19 (73%) cases of combined pulmonary valve replacement. Prospective, multicentre studies are warranted to better define the management strategy and to identify biomarkers associated with outcome in CHD.

Heart Disease 40

Heart Disease Tricuspid Outcomes Heart Failure 40

Circulation

NOVEMBER 11, 2024

Blood samples for biomarker analyses, including IL-6, were collected.Results:There were 64 consecutive STEMI patients. Patients with IL-6 concentrations cut-off point showed a significantly higher time of STEMI, GOT, higher pulmonary arterial pressure, and longitudinal tracking of left atrial diameter. There was 75% of males.

STEMI 40

STEMI Myocardial Infarction Tricuspid Biomarkers 40

Journal of Cardiovascular Electrophysiology

DECEMBER 17, 2023

This study investigated myocardial injury and inflammation following pulmonary vein isolation using (1) Standard radiofrequency ablation, (2) very high-power short-duration (vHPSD)-70W, (3) vHPSD-90W, and (4) pulsed-field ablation (PFA).

Ablation 40

Ablation Atrial Fibrillation Technology Pulmonary 40

Journal of Cardiovascular Electrophysiology

DECEMBER 17, 2024

This study aimed to quantify the impact of PEF energy on erythrocyte damage during AF ablation by assessing specific hemolytic biomarkers. Ablation beyond pulmonary vein isolation was performed at the operator's discretion.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Biomarkers Pulmonary 40

Dr. Smith's ECG Blog

DECEMBER 14, 2016

The patient had been on a long drive, suggesting possible pulmonary embolism (this was unlikely given absence of tachyardia, hypoxia, or any other feature of PE), so we sent a d dimer. [We Patients with ACS and acute pulmonary edema 3. Owing to a poor short- and long-term prognosis if left untreated, an immediate (i.e.

Chest Pain 52

Chest Pain STEMI Aortic Myocardial Infarction 52

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

Pulmonary Arterial Hypertension (PAH): Hasan Ahmad Khasawneh’s (Jordan) systematic review of Treprostinil safety in PAH patients revealed no significant increase in mortality, though adverse events were more frequent. REVERSE-FLOW Trial: Prof. Dr. Ingel Eitel (Germany) presented the randomized REVERSE-FLOW trial as Late Breaking Science.

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59

Open Heart

APRIL 6, 2023

We aim to characterise the response to perioperative injury for patients undergoing repair or pulmonary valve replacement (PVR) for tetralogy of Fallot (ToF). Ninety-two serum biomarkers were expressed as principal components to reduce multiple statistical testing. Serum biomarkers were expressed as three principal components.

Biomarkers 52

Biomarkers Pulmonary 52

European Journal of Heart Failure

NOVEMBER 26, 2024

( A ) Univariable receiver operating characteristic (ROC) curves for all biomarkers. ( Abstract Aims Traditional cardiovascular (CV) biomarkers (high-sensitivity troponinT [hsTnT] and N-terminal pro-B-type natriuretic peptide [NT-proBNP]) are important to monitor cancer patients' cardiac function and to assess prognosis.

Biomarkers 40

Biomarkers Cancer Laboratory Cardiac Function 40

Circulation

NOVEMBER 11, 2024

We compared characteristics at enrollment between men and women with respect to symptoms, physical exam, biomarkers, imaging, and hemodynamics.Results:Women were more likely than men to be non-white (52% vs. 36%, p=0.02) with a non-ischemic etiology (69% vs. 44%, p<0.001). p=0.008) and more physical signs of congestion (10.7±2.3

Heart Failure 40

Heart Failure Biomarkers Pulmonary Bicuspid/Mitral 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

ECG Cases

APRIL 1, 2025

What role do risk scores, biomarkers, imaging, and hemodynamics play in decision-making? The post Ep 203 Intermediate Risk Pulmonary Embolism Risk Stratification, Management and Algorithm appeared first on Emergency Medicine Cases. How do you predict which intermediate-risk patients will suddenly deteriorate?

Embolism 87

Embolism Pulmonary Thrombolysis Biomarkers 87

Frontiers in Cardiovascular Medicine

MARCH 17, 2025

ConclusionsDapagliflozin induced positive LV remodeling, improvement of exercise ventilatory efficiency, and NYHA class but without peakVO2 fluid status and cardiac biomarkers changes. ResultsNone of the patients interrupted SGLT2-i for adverse events albeit follow-up was completed by 67 of 75 enrolled patients.

Exercise 40

Exercise Biomarkers Heart Failure Pulmonary 40

Open Heart

NOVEMBER 27, 2024

Methods Patients with rate-controlled persistent AF and LVEF<50% undergoing catheter ablation (CA) were prospectively evaluated using echocardiography, cardio-pulmonary exercise testing and serum N-terminal pro b-type natriuretic peptide (NT-proBNP) at baseline and 6 months after CA.

Atrial Fibrillation 52

Atrial Fibrillation Cardiomyopathy Ablation Cardiac Function 52

Dr. Smith's ECG Blog

FEBRUARY 26, 2025

Both reperfusion, as judged by the biomarker curve, and patency, as assessed by the angiogram, were correlated with the rapidity and depth of T wave inversion. Rupture can be either free wall rupture (causing tamponade) or septal rupture, causing ventricular septal defect with left to right flow and resulting pulmonary edema and shock.

Chest Pain 89

Chest Pain Pericarditis Myocardial Infarction Dementia 89